BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37455528)

  • 1. ESM-1 Mediates Cell Progression in Clear Cell Renal Cell Carcinoma by Affecting Wnt/β-Catenin Signalling Pathway.
    Liu X; Wang F; Du W; Yang X
    Arch Esp Urol; 2023 Jun; 76(4):290-297. PubMed ID: 37455528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
    Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
    Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling.
    Lu J; Wei JH; Feng ZH; Chen ZH; Wang YQ; Huang Y; Fang Y; Liang YP; Cen JJ; Pan YH; Liao B; Chen WF; Chen W; Luo JH
    Oncotarget; 2017 Mar; 8(13):21461-21471. PubMed ID: 28423523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of SDHA inhibited proliferation, migration, and invasion of clear cell renal cell carcinoma cells via inactivation of the Wnt/β-catenin pathway.
    Xu X; Zhang N; Gao R; Wang J; Dai Z; Bi J
    J Recept Signal Transduct Res; 2022 Apr; 42(2):180-188. PubMed ID: 33602019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00675 suppresses proliferative, migration and invasion of clear cell renal cell carcinoma via the Wnt/β-catenin pathway.
    Zhu L; Liu XL; Fu ZQ; Qiu P; Feng T; Yan B; Wei JL
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2313-2320. PubMed ID: 32196582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.
    Song X; Liu J; Liu B; Piao C; Kong C; Li Z
    Cancer Med; 2023 Mar; 12(5):5764-5780. PubMed ID: 36200301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilevel Regulation of β-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma.
    Rao H; Li X; Liu M; Liu J; Feng W; Tang H; Xu J; Gao WQ; Li L
    Cancer Res; 2021 Jul; 81(13):3554-3567. PubMed ID: 33910928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
    Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome.
    Xue YJ; Chen SN; Chen WG; Wu GQ; Liao YF; Xu JB; Tang H; Yang SH; He SY; Luo YF; Wu ZH; Huang HW
    J Exp Clin Cancer Res; 2019 Aug; 38(1):378. PubMed ID: 31455359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway.
    Wang Q; Xu J; Xiong Z; Xu T; Liu J; Liu Y; Chen J; Shi J; Shou Y; Yue C; Liu D; Liang H; Yang H; Yang X; Zhang X
    J Transl Med; 2021 Oct; 19(1):417. PubMed ID: 34627268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kindlin‑2 promotes clear cell renal cell carcinoma progression through the Wnt signaling pathway.
    Li M; Pei X; Wang G; Zhan J; Du J; Jiang H; Tang Y; Zhang H; He H
    Oncol Rep; 2017 Sep; 38(3):1551-1560. PubMed ID: 28677779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE3C promotes growth and metastasis of renal cell carcinoma via activating Wnt/β-catenin pathway.
    Wen JL; Wen XF; Li RB; Jin YC; Wang XL; Zhou L; Chen HX
    PLoS One; 2015; 10(2):e0115622. PubMed ID: 25658088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
    Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
    PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ENST00000434223 inhibits the progression of renal cancer through Wnt/hygro-catenin signaling pathway.
    Luo NQ; Ma DR; Yang XC; Liu Y; Zhou P; Guo LJ; Huang XD
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6868-6877. PubMed ID: 31486486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression.
    Ji J; Xu Y; Xie M; He X; Ren D; Qiu T; Liu W; Chen Z; Shi W; Zhang Z; Wang X; Wang W; Ma J; Qian Q; Jing A; Ma X; Qin J; Ding Y; Geng T; Yang J; Sun Z; Liu W; Liu S; Liu B
    Cell Death Dis; 2023 Feb; 14(2):83. PubMed ID: 36739418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling.
    Chi XG; Meng XX; Ding DL; Xuan XH; Chen YZ; Cai Q; Wang A
    Neoplasma; 2020 Jan; 67(1):46-53. PubMed ID: 31686521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs.
    Gorka J; Marona P; Kwapisz O; Waligórska A; Pospiech E; Dobrucki JW; Rys J; Jura J; Miekus K
    Oncogene; 2021 Dec; 40(50):6720-6735. PubMed ID: 34657130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRMT7 promotes the growth of renal cell carcinoma through modulating the β-catenin/C-MYC axis.
    Liu F; Wan L; Zou H; Pan Z; Zhou W; Lu X
    Int J Biochem Cell Biol; 2020 Mar; 120():105686. PubMed ID: 31926310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.